CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

yahoo_finance
Original article

Citi raises AstraZeneca target to £186 as tozorakimab prospects improve

tozorakimabPositive
AI Analysis

Summary

Citi raised AstraZeneca's price target to £186 citing improved prospects for the drug tozorakimab.

Importance:4/10
Sentiment:
0.70
analyst_upgradeprice_target_increaseAstraZenecatozorakimab
Related Companies

Read the original article

Published by yahoo_finance on October 6, 2026 1:00 PM

Read Original